---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-020272"
form_type: "8-K"
ticker: null
cik: "0001522860"
company_name: "Acutus Medical, Inc."
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T23:08:04.584112+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Acutus Medical receives Nasdaq delisting notice; stock to suspend May 9

## Summary
- Nasdaq notified Acutus Medical of non-compliance with minimum bid price ($1.00) and stockholders' equity ($2.5M) requirements.
- Company will not appeal; common stock will be suspended from Nasdaq at open on May 9, 2024.
- Shares expected to trade on OTC Pink Sheets; no assurance of market development.
- Previously received compliance periods ending April 29, 2024, but failed to regain compliance.

## SEC filing metadata
- accession: 0001628280-24-020272
- form_type: 8-K
- cik: 0001522860
- company_name: Acutus Medical, Inc.
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/0001628280-24-020272-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/afib-20240430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-020272
- JSON: https://secwatch.observer/filing/0001628280-24-020272.json
- Plain text: https://secwatch.observer/filing/0001628280-24-020272.txt

## Key facts
- Listing & Compliance Notices
  Acutus Medical, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b), 5810(d)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: stockholders equity
  - Rules: 5550(b), 5810(d)(2)
  source text: April 30, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2). The Staff also notified the Company, as a separate basis for delisting pursuant to Listing Rule 5810(d)(2), that the Company is not in compliance with Listing Rule 5550(b) for failure to maintain stockholders’ equity of at least $2.5 million, or either of the alternatives to compliance with this standard ((i) market value of listed securities of $35 million or (ii) net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last thre
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/0001628280-24-020272-index.htm
- Listing & Compliance Notices
  Acutus Medical, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A), 5550(a)(2), 5810(d)(2), 5550(b)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A), 5550(a)(2), 5810(d)(2), 5550(b)
  source text: April 30, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2). The Staff also notified the Company, as a separate basis for delisting pursuant to Listing Rule 5810(d)(2), that the Company is not in compliance with Listing Rule 5550(b) for failure to maintain stockholders’ equity of at least $2.5 million, or either of the alternatives to compliance with this standard ((i) market value of listed securities of $35 million or (ii) net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last thre
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/0001628280-24-020272-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.